MARKET OUTLOOK

This report suggests that the Latin America epilepsy devices market is expected to observe growth at a compound annual growth rate of 7.53% during the forecast years 2022-2028. Brazil, Mexico, and Rest of Latin America are assessed in the studied region.
In Mexico, epilepsy is among the major diseases that result in high mortality. Moreover, the rise in road traffic accidents has increased epilepsy seizures. In this regard, CT scans or MRI systems are majorly deployed to detect epilepsy nationwide. Furthermore, government initiatives and healthcare programs are creating awareness about epilepsy. Therefore, such steps are anticipated to open new avenues for the epilepsy devices market.
Furthermore, in Argentina, the market’s growth is supported by advances in diagnostic techniques. Moreover, knowledge of underlying pathophysiology has surged the efficacy of surgical procedures, thus increasing the patient pool for epilepsy surgery. For instance, refractory non-lesional focal epilepsy case operations have derived promising results. Hence, as stated above, these factors boost the epilepsy devices market’s development.

COMPETITIVE OUTLOOK

The key enterprises in the epilepsy devices market include Natus Medical Incorporated, LivaNova Plc, Medtronic Plc, Boston Scientific Corporation, and Neurosoft.

TABLE OF CONTENTS

1. LATIN AMERICA EPILEPSY DEVICES MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON THE EPILEPSY DEVICES MARKET
2.2. KEY INSIGHTS
2.2.1. GROWING USE OF TELEMEDICINE SERVICES
2.2.2. INCREASE IN DRUG AND DEVICE TRIALS FOR EPILEPSY
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTES
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. KEY BUYING IMPACT ANALYSIS
2.4.1. COMFORT & USABILITY
2.4.2. PRODUCT FEATURES
2.4.3. CONFIDENTIALITY
2.5. MARKET ATTRACTIVENESS INDEX
2.6. VENDOR SCORECARD
2.7. INDUSTRY COMPONENTS
2.8. REGULATORY FRAMEWORK
2.9. KEY MARKET STRATEGIES
2.9.1. DEVELOPMENTS & PRODUCT LAUNCHES
2.9.2. COLLABORATIONS
2.9.3. ACQUISITIONS
2.10. MARKET DRIVERS
2.10.1. COMBATING EPILEPSY THROUGH EARLY DETECTION AND DIAGNOSIS
2.10.2. RISING PREVALENCE OF EPILEPSY
2.11. MARKET CHALLENGES
2.11.1. UNAWARENESS ABOUT EPILEPSY AMONG THE GENERAL MASSES
2.11.2. LACK OF NEUROLOGY SPECIALISTS IN THE HEALTHCARE SYSTEM
2.12. MARKET OPPORTUNITIES
2.12.1. R&D ACTIVITIES DUE TO GROWING EPILEPSY CASES IN OLD PEOPLE
2.12.2. ASCENDING POST-TRAUMATIC EPILEPSY (PTE) CASES DUE TO BRAIN INJURIES
2.12.3. TECHNOLOGICAL ADVANCES IN NON-INVASIVE WEARABLE SENSORS
3. LATIN AMERICA EPILEPSY DEVICES MARKET OUTLOOK – BY DEVICE TYPE
3.1. TRADITIONAL DEVICES
3.2. WEARABLE DEVICES
3.2.1. WATCHES
3.2.2. BRACELETS
3.2.3. CAMERA DEVICES
3.2.4. MATTRESS DEVICES
3.2.5. ANTI-SUFFOCATION PILLOWS
3.2.6. OTHER WEARABLE DEVICES
3.3. IMPLANTABLE DEVICES
4. LATIN AMERICA EPILEPSY DEVICES MARKET OUTLOOK – BY APPLICATION
4.1. VAGUS NERVE STIMULATION
4.2. DEEP BRAIN STIMULATION
4.2.1. MOVEMENT DISORDERS
4.2.2. EPILEPSY
4.3. ACCELEROMETER
4.4. RESPONSIVE NEUROSTIMULATION
5. LATIN AMERICA EPILEPSY DEVICES MARKET OUTLOOK – BY DETECTION AND PREDICTION DEVICE TYPE
5.1. ELECTROENCEPHALOGRAM
5.2. INTRACRANIAL EEG
5.3. SURFACE ELECTROMYOGRAPHY
5.4. ELECTROCARDIOGRAPHY
5.5. VIDEO DETECTION SYSTEMS
5.6. ELECTRODERMAL ACTIVITY
5.7. IMPLANTED ADVISORY SYSTEMS
5.8. OTHER DETECTION AND PREDICTION DEVICE TYPES
6. LATIN AMERICA EPILEPSY DEVICES MARKET OUTLOOK – BY END-USER
6.1. HOSPITALS & CLINICS
6.2. NEUROLOGY CENTERS
6.3. HOMECARE SETTINGS
6.4. OTHER END-USERS
7. LATIN AMERICA EPILEPSY DEVICES MARKET – COUNTRY OUTLOOK
7.1. BRAZIL
7.2. MEXICO
7.3. REST OF LATIN AMERICA
8. COMPETITIVE LANDSCAPE
8.1. LIVANOVA PLC
8.2. NATUS MEDICAL INCORPORATED
8.3. CADWELL INDUSTRIES INC
8.4. NIHON KOHDEN CORPORATION
8.5. COMPUMEDICS LIMITED
8.6. MEDTRONIC PLC
8.7. BOSTON SCIENTIFIC CORPORATION
8.8. EMPATICA INC
8.9. KONINKLIJKE PHILIPS NV
8.10. NEUROPACE INC
8.11. DRÄGERWERK AG & CO KGAA
8.12. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO LTD
8.13. NEUROSOFT
9. RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.2. SOURCES OF DATA
9.3. RESEARCH METHODOLOGY

LIST OF TABLES
TABLE 1: LATIN AMERICA EPILEPSY DEVICES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: REGULATORY FRAMEWORK
TABLE 4: LIST OF PRODUCT LAUNCHES
TABLE 5: LIST OF COLLABORATIONS
TABLE 6: LIST OF ACQUISITIONS
TABLE 7: EXAMPLES OF ANTIEPILEPTIC DRUGS FOR THE ELDERLY AND THEIR ADVANTAGES
TABLE 8: EXAMPLE OF MOBILE EEG DEVICES
TABLE 9: LATIN AMERICA EPILEPSY DEVICES MARKET, BY DEVICE TYPE, 2022-2028 (IN $ MILLION)
TABLE 10: LATIN AMERICA EPILEPSY DEVICES MARKET, BY WEARABLE DEVICE, 2022-2028 (IN $ MILLION)
TABLE 11: LATIN AMERICA EPILEPSY DEVICES MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 12: LATIN AMERICA EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2022-2028 (IN $ MILLION)
TABLE 13: LATIN AMERICA EPILEPSY DEVICES MARKET, BY DETECTION AND PREDICTION DEVICE TYPE, 2022-2028 (IN $ MILLION)
TABLE 14: LATIN AMERICA EPILEPSY DEVICES MARKET, BY END-USER, 2022-2028 (IN $ MILLION)
TABLE 15: LATIN AMERICA EPILEPSY DEVICES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

LIST OF FIGURES
FIGURE 1: KEY BUYING IMPACT ANALYSIS
FIGURE 2: MARKET ATTRACTIVENESS INDEX
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: LATIN AMERICA EPILEPSY DEVICES MARKET, BY DEVICE TYPE, 2021 & 2028 (IN %)
FIGURE 5: LATIN AMERICA EPILEPSY DEVICES MARKET, BY TRADITIONAL DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 6: LATIN AMERICA EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 7: LATIN AMERICA EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2021 & 2028 (IN %)
FIGURE 8: LATIN AMERICA EPILEPSY DEVICES MARKET, BY WATCHES, 2022-2028 (IN $ MILLION)
FIGURE 9: LATIN AMERICA EPILEPSY DEVICES MARKET, BY BRACELETS, 2022-2028 (IN $ MILLION)
FIGURE 10: LATIN AMERICA EPILEPSY DEVICES MARKET, BY CAMERA DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 11: LATIN AMERICA EPILEPSY DEVICES MARKET, BY MATTRESS DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 12: LATIN AMERICA EPILEPSY DEVICES MARKET, BY ANTI-SUFFOCATION PILLOWS, 2022-2028 (IN $ MILLION)
FIGURE 13: LATIN AMERICA EPILEPSY DEVICES MARKET, BY OTHER WEARABLE DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 14: LATIN AMERICA EPILEPSY DEVICES MARKET, BY IMPLANTABLE DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 15: LATIN AMERICA EPILEPSY DEVICES MARKET, BY APPLICATION, 2021 & 2028 (IN %)
FIGURE 16: LATIN AMERICA EPILEPSY DEVICES MARKET, BY VAGUS NERVE STIMULATION, 2022-2028 (IN $ MILLION)
FIGURE 17: LATIN AMERICA EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2022-2028 (IN $ MILLION)
FIGURE 18: LATIN AMERICA EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2021 & 2028 (IN %)
FIGURE 19: LATIN AMERICA EPILEPSY DEVICES MARKET, BY MOVEMENT DISORDERS, 2022-2028 (IN $ MILLION)
FIGURE 20: LATIN AMERICA EPILEPSY DEVICES MARKET, BY EPILEPSY, 2022-2028 (IN $ MILLION)
FIGURE 21: LATIN AMERICA EPILEPSY DEVICES MARKET, BY ACCELEROMETER, 2022-2028 (IN $ MILLION)
FIGURE 22: LATIN AMERICA EPILEPSY DEVICES MARKET, BY RESPONSIVE NEUROSTIMULATION, 2022-2028 (IN $ MILLION)
FIGURE 23: LATIN AMERICA EPILEPSY DEVICES MARKET, BY DETECTION AND PREDICTION DEVICES TYPE, 2021 & 2028 (IN %)
FIGURE 24: LATIN AMERICA EPILEPSY DEVICES MARKET, BY ELECTROENCEPHALOGRAM, 2022-2028 (IN $ MILLION)
FIGURE 25: LATIN AMERICA EPILEPSY DEVICES MARKET, BY INTRACRANIAL EEG, 2022-2028 (IN $ MILLION)
FIGURE 26: LATIN AMERICA EPILEPSY DEVICES MARKET, BY SURFACE ELECTROMYOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 27: LATIN AMERICA EPILEPSY DEVICES MARKET, BY ELECTROCARDIOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 28: LATIN AMERICA EPILEPSY DEVICES MARKET, BY VIDEO DETECTION SYSTEMS, 2022-2028 (IN $ MILLION)
FIGURE 29: LATIN AMERICA EPILEPSY DEVICES MARKET, BY ELECTRODERMAL ACTIVITY, 2022-2028 (IN $ MILLION)
FIGURE 30: LATIN AMERICA EPILEPSY DEVICES MARKET, BY IMPLANTED ADVISORY SYSTEMS, 2022-2028 (IN $ MILLION)
FIGURE 31: LATIN AMERICA EPILEPSY DEVICES MARKET, BY OTHER PREDICTION AND DETECTION DEVICE TYPES, 2022-2028 (IN $ MILLION)
FIGURE 32: LATIN AMERICA EPILEPSY DEVICES MARKET, BY END-USER, 2021 & 2028 (IN %)
FIGURE 33: LATIN AMERICA EPILEPSY DEVICES MARKET, BY HOSPITALS & CLINICS, 2022-2028 (IN $ MILLION)
FIGURE 34: LATIN AMERICA EPILEPSY DEVICES MARKET, BY NEUROLOGY CENTERS, 2022-2028 (IN $ MILLION)
FIGURE 35: LATIN AMERICA EPILEPSY DEVICES MARKET, BY HOMECARE SETTINGS, 2022-2028 (IN $ MILLION)
FIGURE 36: LATIN AMERICA EPILEPSY DEVICES MARKET, BY OTHER END-USERS, 2022-2028 (IN $ MILLION)
FIGURE 37: LATIN AMERICA EPILEPSY DEVICES MARKET, BY COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 38: BRAZIL EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 39: MEXICO EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 40: REST OF LATIN AMERICA EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)

The post LATIN AMERICA EPILEPSY DEVICES MARKET 2022-2028 first appeared on CRI Report.

MARKET OUTLOOK

This report insinuates that the Middle East and Africa epilepsy devices market is deemed to advance at a compound annual growth rate of 7.43% during the forecast years 2022-2028. Saudi Arabia, South Africa, the United Arab Emirates, Turkey, and Rest of Middle East & Africa are researched in this region.
In recent years, sudden epilepsy-induced deaths have become a major concern in Turkey. Other than this, discounting antiepileptic treatments due to maternal concerns and changing medication metabolism during pregnancy have resulted in serious seizure-related issues. The higher rates of concomitant maternal co-morbidities and severe obstetric issues elevate the demand for efficient epilepsy equipment. Therefore, as stated above, these factors are anticipated to drive the epilepsy devices market.
On the flip side, since genomic technology development is expensive, cost-effective alternatives like wearable technology have become popular in South Africa. The establishment of laboratories and clinical services is another factor supporting the adoption of advanced epilepsy monitoring equipment. Besides this, several outreach programs to raise awareness are expected to drive the demand for these devices, creating opportunities for the epilepsy devices market.

COMPETITIVE OUTLOOK

The well-known firms in the epilepsy devices market include Cadwell Industries Inc, LivaNova Plc, Nihon Kohden Corporation, Natus Medical Incorporated, and Medtronic Plc.

TABLE OF CONTENTS

1. MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON THE EPILEPSY DEVICES MARKET
2.2. KEY INSIGHTS
2.2.1. GROWING USE OF TELEMEDICINE SERVICES
2.2.2. INCREASE IN DRUG AND DEVICE TRIALS FOR EPILEPSY
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTES
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. KEY BUYING IMPACT ANALYSIS
2.4.1. COMFORT & USABILITY
2.4.2. PRODUCT FEATURES
2.4.3. CONFIDENTIALITY
2.5. MARKET ATTRACTIVENESS INDEX
2.6. VENDOR SCORECARD
2.7. INDUSTRY COMPONENTS
2.8. REGULATORY FRAMEWORK
2.9. KEY MARKET STRATEGIES
2.9.1. DEVELOPMENTS & PRODUCT LAUNCHES
2.9.2. COLLABORATIONS
2.9.3. ACQUISITIONS
2.10. MARKET DRIVERS
2.10.1. COMBATING EPILEPSY THROUGH EARLY DETECTION AND DIAGNOSIS
2.10.2. RISING PREVALENCE OF EPILEPSY
2.11. MARKET CHALLENGES
2.11.1. UNAWARENESS ABOUT EPILEPSY AMONG THE GENERAL MASSES
2.11.2. LACK OF NEUROLOGY SPECIALISTS IN THE HEALTHCARE SYSTEM
2.12. MARKET OPPORTUNITIES
2.12.1. R&D ACTIVITIES DUE TO GROWING EPILEPSY CASES IN OLD PEOPLE
2.12.2. ASCENDING POST-TRAUMATIC EPILEPSY (PTE) CASES DUE TO BRAIN INJURIES
2.12.3. TECHNOLOGICAL ADVANCES IN NON-INVASIVE WEARABLE SENSORS FOR EPILEPSY
3. MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET OUTLOOK – BY DEVICE TYPE
3.1. TRADITIONAL DEVICES
3.2. WEARABLE DEVICES
3.2.1. WATCHES
3.2.2. BRACELETS
3.2.3. CAMERA DEVICES
3.2.4. MATTRESS DEVICES
3.2.5. ANTI-SUFFOCATION PILLOWS
3.2.6. OTHER WEARABLE DEVICES
3.3. IMPLANTABLE DEVICES
4. MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET OUTLOOK – BY APPLICATION
4.1. VAGUS NERVE STIMULATION
4.2. DEEP BRAIN STIMULATION
4.2.1. MOVEMENT DISORDERS
4.2.2. EPILEPSY
4.3. ACCELEROMETER
4.4. RESPONSIVE NEUROSTIMULATION
5. MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET OUTLOOK – BY DETECTION AND PREDICTION DEVICE TYPE
5.1. ELECTROENCEPHALOGRAM
5.2. INTRACRANIAL EEG
5.3. SURFACE ELECTROMYOGRAPHY
5.4. ELECTROCARDIOGRAPHY
5.5. VIDEO DETECTION SYSTEMS
5.6. ELECTRODERMAL ACTIVITY
5.7. IMPLANTED ADVISORY SYSTEMS
5.8. OTHER DETECTION AND PREDICTION DEVICE TYPES
6. MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET OUTLOOK – BY END-USER
6.1. HOSPITALS & CLINICS
6.2. NEUROLOGY CENTERS
6.3. HOMECARE SETTINGS
6.4. OTHER END-USERS
7. MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET – COUNTRY OUTLOOK
7.1. UNITED ARAB EMIRATES
7.2. SAUDI ARABIA
7.3. TURKEY
7.4. SOUTH AFRICA
7.5. REST OF MIDDLE EAST & AFRICA
8. COMPETITIVE LANDSCAPE
8.1. LIVANOVA PLC
8.2. NATUS MEDICAL INCORPORATED
8.3. CADWELL INDUSTRIES INC
8.4. NIHON KOHDEN CORPORATION
8.5. COMPUMEDICS LIMITED
8.6. MEDTRONIC PLC
8.7. BOSTON SCIENTIFIC CORPORATION
8.8. EMPATICA INC
8.9. KONINKLIJKE PHILIPS NV
8.10. NEUROPACE INC
8.11. DRÄGERWERK AG & CO KGAA
8.12. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO LTD
8.13. NEUROSOFT
9. RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.2. SOURCES OF DATA
9.3. RESEARCH METHODOLOGY

LIST OF TABLES
TABLE 1: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: REGULATORY FRAMEWORK
TABLE 4: LIST OF PRODUCT LAUNCHES
TABLE 5: LIST OF COLLABORATIONS
TABLE 6: LIST OF ACQUISITIONS
TABLE 7: EXAMPLES OF ANTIEPILEPTIC DRUGS FOR THE ELDERLY AND THEIR ADVANTAGES
TABLE 8: EXAMPLE OF MOBILE EEG DEVICES
TABLE 9: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY DEVICE TYPE, 2022-2028 (IN $ MILLION)
TABLE 10: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2022-2028 (IN $ MILLION)
TABLE 11: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 12: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2022-2028 (IN $ MILLION)
TABLE 13: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY DETECTION AND PREDICTION DEVICE TYPE, 2022-2028 (IN $ MILLION)
TABLE 14: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY END-USER, 2022-2028 (IN $ MILLION)
TABLE 15: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

LIST OF FIGURES
FIGURE 1: KEY BUYING IMPACT ANALYSIS
FIGURE 2: MARKET ATTRACTIVENESS INDEX
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY DEVICE TYPE, 2021 & 2028 (IN %)
FIGURE 5: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY TRADITIONAL DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 6: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 7: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2021 & 2028 (IN %)
FIGURE 8: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY WATCHES, 2022-2028 (IN $ MILLION)
FIGURE 9: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY BRACELETS, 2022-2028 (IN $ MILLION)
FIGURE 10: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY CAMERA DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 11: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY MATTRESS DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 12: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY ANTI-SUFFOCATION PILLOWS, 2022-2028 (IN $ MILLION)
FIGURE 13: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY OTHER WEARABLE DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 14: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY IMPLANTABLE DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 15: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY APPLICATION, 2021 & 2028 (IN %)
FIGURE 16: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY VAGUS NERVE STIMULATION, 2022-2028 (IN $ MILLION)
FIGURE 17: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2022-2028 (IN $ MILLION)
FIGURE 18: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2021 & 2028 (IN %)
FIGURE 19: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY MOVEMENT DISORDERS, 2022-2028 (IN $ MILLION)
FIGURE 20: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY EPILEPSY, 2022-2028 (IN $ MILLION)
FIGURE 21: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY ACCELEROMETER, 2022-2028 (IN $ MILLION)
FIGURE 22: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY RESPONSIVE NEUROSTIMULATION, 2022-2028 (IN $ MILLION)
FIGURE 23: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY DETECTION AND PREDICTION DEVICES TYPE, 2021 & 2028 (IN %)
FIGURE 24: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY ELECTROENCEPHALOGRAM, 2022-2028 (IN $ MILLION)
FIGURE 25: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY INTRACRANIAL EEG, 2022-2028 (IN $ MILLION)
FIGURE 26: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY SURFACE ELECTROMYOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 27: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY ELECTROCARDIOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 28: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY VIDEO DETECTION SYSTEMS, 2022-2028 (IN $ MILLION)
FIGURE 29: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY ELECTRODERMAL ACTIVITY, 2022-2028 (IN $ MILLION)
FIGURE 30: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY IMPLANTED ADVISORY SYSTEMS, 2022-2028 (IN $ MILLION)
FIGURE 31: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY OTHER PREDICTION AND DETECTION DEVICE TYPES, 2022-2028 (IN $ MILLION)
FIGURE 32: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY END-USER, 2021 & 2028 (IN %)
FIGURE 33: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY HOSPITALS & CLINICS, 2022-2028 (IN $ MILLION)
FIGURE 34: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY NEUROLOGY CENTERS, 2022-2028 (IN $ MILLION)
FIGURE 35: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY HOMECARE SETTINGS, 2022-2028 (IN $ MILLION)
FIGURE 36: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY OTHER END-USERS, 2022-2028 (IN $ MILLION)
FIGURE 37: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 38: UNITED ARAB EMIRATES EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 39: SAUDI ARABIA EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 40: TURKEY EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 41: SOUTH AFRICA EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 42: REST OF MIDDLE EAST & AFRICA EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)

The post MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET 2022-2028 first appeared on CRI Report.

MARKET OUTLOOK

According to this report, the epilepsy devices market in North America is estimated to gather a compound annual growth rate of 8.34% over the forecast years 2022 to 2028. The United States and Canada are examined in the region.
Factors such as advanced healthcare infrastructure, government policies, and key players expanding operations are fueling the market on a progressive path. Companies like Boston Scientific Corporation and Empatica are among the major firms launching new products to gain a competitive edge in the studied market. This is mainly owing to the rise in epilepsy cases across the US and Canada. As per industry sources, around one in 26 people are diagnosed with epilepsy once in their lifetime. Therefore, the rising cases are anticipated to boost the adoption of epilepsy monitoring devices over the forecast period.
Considering the market’s growth in the US, there is a rise in epilepsy cases among the elderly population that has soared the demand for effective treatment measures. In this regard, wearable devices and homecare treatments have gained momentum in recent years. The prominent wearable devices include watches, cameras, anti-suffocation pillows, and bracelets. As a result, the rising need for advanced medical technologies to treat seizures propels the epilepsy devices market on a growth path.

COMPETITIVE OUTLOOK

The major enterprises in the epilepsy devices market consist of LivaNova Plc, Cadwell Industries Inc, Nihon Kohden Corporation, Medtronic Plc, and Boston Scientific Corporation.

TABLE OF CONTENTS

1. NORTH AMERICA EPILEPSY DEVICES MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON THE EPILEPSY DEVICES MARKET
2.2. KEY INSIGHTS
2.2.1. GROWING USE OF TELEMEDICINE SERVICES
2.2.2. INCREASE IN DRUG AND DEVICE TRIALS FOR EPILEPSY
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTES
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. KEY BUYING IMPACT ANALYSIS
2.4.1. COMFORT & USABILITY
2.4.2. PRODUCT FEATURES
2.4.3. CONFIDENTIALITY
2.5. MARKET ATTRACTIVENESS INDEX
2.6. VENDOR SCORECARD
2.7. INDUSTRY COMPONENTS
2.8. REGULATORY FRAMEWORK
2.9. KEY MARKET STRATEGIES
2.9.1. DEVELOPMENTS & PRODUCT LAUNCHES
2.9.2. COLLABORATIONS
2.9.3. ACQUISITIONS
2.10. MARKET DRIVERS
2.10.1. COMBATING EPILEPSY THROUGH EARLY DETECTION AND DIAGNOSIS
2.10.2. RISING PREVALENCE OF EPILEPSY
2.11. MARKET CHALLENGES
2.11.1. UNAWARENESS ABOUT EPILEPSY AMONG THE GENERAL MASSES
2.11.2. LACK OF NEUROLOGY SPECIALISTS IN THE HEALTHCARE SYSTEM
2.12. MARKET OPPORTUNITIES
2.12.1. R&D ACTIVITIES DUE TO GROWING EPILEPSY CASES IN OLD PEOPLE
2.12.2. ASCENDING POST-TRAUMATIC EPILEPSY (PTE) CASES DUE TO BRAIN INJURIES
2.12.3. TECHNOLOGICAL ADVANCES IN NON-INVASIVE WEARABLE SENSORS FOR EPILEPSY
3. NORTH AMERICA EPILEPSY DEVICES MARKET OUTLOOK – BY DEVICE TYPE
3.1. TRADITIONAL DEVICES
3.2. WEARABLE DEVICES
3.2.1. WATCHES
3.2.2. BRACELETS
3.2.3. CAMERA DEVICES
3.2.4. MATTRESS DEVICES
3.2.5. ANTI-SUFFOCATION PILLOWS
3.2.6. OTHER WEARABLE DEVICES
3.3. IMPLANTABLE DEVICES
4. NORTH AMERICA EPILEPSY DEVICES MARKET OUTLOOK – BY APPLICATION
4.1. VAGUS NERVE STIMULATION
4.2. DEEP BRAIN STIMULATION
4.2.1. MOVEMENT DISORDERS
4.2.2. EPILEPSY
4.3. ACCELEROMETER
4.4. RESPONSIVE NEUROSTIMULATION
5. NORTH AMERICA EPILEPSY DEVICES MARKET OUTLOOK – BY DETECTION AND PREDICTION DEVICE TYPE
5.1. ELECTROENCEPHALOGRAM
5.2. INTRACRANIAL EEG
5.3. SURFACE ELECTROMYOGRAPHY
5.4. ELECTROCARDIOGRAPHY
5.5. VIDEO DETECTION SYSTEMS
5.6. ELECTRODERMAL ACTIVITY
5.7. IMPLANTED ADVISORY SYSTEMS
5.8. OTHER DETECTION AND PREDICTION DEVICE TYPES
6. NORTH AMERICA EPILEPSY DEVICES MARKET OUTLOOK – BY END-USER
6.1. HOSPITALS & CLINICS
6.2. NEUROLOGY CENTERS
6.3. HOMECARE SETTINGS
6.4. OTHER END-USERS
7. NORTH AMERICA EPILEPSY DEVICES MARKET – COUNTRY OUTLOOK
7.1. UNITED STATES
7.2. CANADA
8. COMPETITIVE LANDSCAPE
8.1. LIVANOVA PLC
8.2. NATUS MEDICAL INCORPORATED
8.3. CADWELL INDUSTRIES INC
8.4. NIHON KOHDEN CORPORATION
8.5. COMPUMEDICS LIMITED
8.6. MEDTRONIC PLC
8.7. BOSTON SCIENTIFIC CORPORATION
8.8. EMPATICA INC
8.9. KONINKLIJKE PHILIPS NV
8.10. NEUROPACE INC
8.11. DRÄGERWERK AG & CO KGAA
8.12. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO LTD
8.13. NEUROSOFT
9. RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.2. SOURCES OF DATA
9.3. RESEARCH METHODOLOGY

LIST OF TABLES
TABLE 1: NORTH AMERICA EPILEPSY DEVICES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: REGULATORY FRAMEWORK
TABLE 4: LIST OF PRODUCT LAUNCHES
TABLE 5: LIST OF COLLABORATIONS
TABLE 6: LIST OF ACQUISITIONS
TABLE 7: EXAMPLES OF ANTIEPILEPTIC DRUGS FOR THE ELDERLY AND THEIR ADVANTAGES
TABLE 8: EXAMPLE OF MOBILE EEG DEVICES
TABLE 9: NORTH AMERICA EPILEPSY DEVICES MARKET, BY DEVICE TYPE, 2022-2028 (IN $ MILLION)
TABLE 10: NORTH AMERICA EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2022-2028 (IN $ MILLION)
TABLE 11: NORTH AMERICA EPILEPSY DEVICES MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 12: NORTH AMERICA EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2022-2028 (IN $ MILLION)
TABLE 13: NORTH AMERICA EPILEPSY DEVICES MARKET, BY DETECTION AND PREDICTION DEVICE TYPE, 2022-2028 (IN $ MILLION)
TABLE 14: NORTH AMERICA EPILEPSY DEVICES MARKET, BY END-USER, 2022-2028 (IN $ MILLION)
TABLE 15: NORTH AMERICA EPILEPSY DEVICES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

LIST OF FIGURES
FIGURE 1: KEY BUYING IMPACT ANALYSIS
FIGURE 2: MARKET ATTRACTIVENESS INDEX
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: NORTH AMERICA EPILEPSY DEVICES MARKET, BY DEVICE TYPE, 2021 & 2028 (IN %)
FIGURE 5: NORTH AMERICA EPILEPSY DEVICES MARKET, BY TRADITIONAL DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 6: NORTH AMERICA EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 7: NORTH AMERICA EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2021 & 2028 (IN %)
FIGURE 8: NORTH AMERICA EPILEPSY DEVICES MARKET, BY WATCHES, 2022-2028 (IN $ MILLION)
FIGURE 9: NORTH AMERICA EPILEPSY DEVICES MARKET, BY BRACELETS, 2022-2028 (IN $ MILLION)
FIGURE 10: NORTH AMERICA EPILEPSY DEVICES MARKET, BY CAMERA DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 11: NORTH AMERICA EPILEPSY DEVICES MARKET, BY MATTRESS DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 12: NORTH AMERICA EPILEPSY DEVICES MARKET, BY ANTI-SUFFOCATION PILLOWS, 2022-2028 (IN $ MILLION)
FIGURE 13: NORTH AMERICA EPILEPSY DEVICES MARKET, BY OTHER WEARABLE DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 14: NORTH AMERICA EPILEPSY DEVICES MARKET, BY IMPLANTABLE DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 15: NORTH AMERICA EPILEPSY DEVICES MARKET, BY APPLICATION, 2021 & 2028 (IN %)
FIGURE 16: NORTH AMERICA EPILEPSY DEVICES MARKET, BY VAGUS NERVE STIMULATION, 2022-2028 (IN $ MILLION)
FIGURE 17: NORTH AMERICA EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2022-2028 (IN $ MILLION)
FIGURE 18: NORTH AMERICA EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2021 & 2028 (IN %)
FIGURE 19: NORTH AMERICA EPILEPSY DEVICES MARKET, BY MOVEMENT DISORDERS, 2022-2028 (IN $ MILLION)
FIGURE 20: NORTH AMERICA EPILEPSY DEVICES MARKET, BY EPILEPSY, 2022-2028 (IN $ MILLION)
FIGURE 21: NORTH AMERICA EPILEPSY DEVICES MARKET, BY ACCELEROMETER, 2022-2028 (IN $ MILLION)
FIGURE 22: NORTH AMERICA EPILEPSY DEVICES MARKET, BY RESPONSIVE NEUROSTIMULATION, 2022-2028 (IN $ MILLION)
FIGURE 23: NORTH AMERICA EPILEPSY DEVICES MARKET, BY DETECTION AND PREDICTION DEVICE TYPE, 2021 & 2028 (IN %)
FIGURE 24: NORTH AMERICA EPILEPSY DEVICES MARKET, BY ELECTROENCEPHALOGRAM, 2022-2028 (IN $ MILLION)
FIGURE 25: NORTH AMERICA EPILEPSY DEVICES MARKET, BY INTRACRANIAL EEG, 2022-2028 (IN $ MILLION)
FIGURE 26: NORTH AMERICA EPILEPSY DEVICES MARKET, BY SURFACE ELECTROMYOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 27: NORTH AMERICA EPILEPSY DEVICES MARKET, BY ELECTROCARDIOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 28: NORTH AMERICA EPILEPSY DEVICES MARKET, BY VIDEO DETECTION SYSTEMS, 2022-2028 (IN $ MILLION)
FIGURE 29: NORTH AMERICA EPILEPSY DEVICES MARKET, BY ELECTRODERMAL ACTIVITY, 2022-2028 (IN $ MILLION)
FIGURE 30: NORTH AMERICA EPILEPSY DEVICES MARKET, BY IMPLANTED ADVISORY SYSTEMS, 2022-2028 (IN $ MILLION)
FIGURE 31: NORTH AMERICA EPILEPSY DEVICES MARKET, BY OTHER PREDICTION AND DETECTION DEVICE TYPES, 2022-2028 (IN $ MILLION)
FIGURE 32: NORTH AMERICA EPILEPSY DEVICES MARKET, BY END-USER, 2021 & 2028 (IN %)
FIGURE 33: NORTH AMERICA EPILEPSY DEVICES MARKET, BY HOSPITALS & CLINICS, 2022-2028 (IN $ MILLION)
FIGURE 34: NORTH AMERICA EPILEPSY DEVICES MARKET, BY NEUROLOGY CENTERS, 2022-2028 (IN $ MILLION)
FIGURE 35: NORTH AMERICA EPILEPSY DEVICES MARKET, BY HOMECARE SETTINGS, 2022-2028 (IN $ MILLION)
FIGURE 36: NORTH AMERICA EPILEPSY DEVICES MARKET, BY OTHER END-USERS, 2022-2028 (IN $ MILLION)
FIGURE 37: NORTH AMERICA EPILEPSY DEVICES MARKET, BY COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 38: UNITED STATES EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 39: CANADA EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)

The post NORTH AMERICA EPILEPSY DEVICES MARKET 2022-2028 first appeared on CRI Report.

MARKET OUTLOOK

Based on This report, the global epilepsy devices market is expected to propel with a CAGR of 8.16% during the forecast period 2022-2028.
Factors such as combating epilepsy through early diagnosis and the rising prevalence of epilepsy are mainly driving the studied market’s growth. Additionally, a surge in R&D activities due to rising epilepsy cases in old people creates novel opportunities for the market.
However, unawareness about the disease and lack of neurology specialists negatively impacts the epilepsy devices market globally.

REGIONAL OUTLOOK

The global epilepsy devices market includes North America, Asia-Pacific, Latin America, Europe, and the Middle East and Africa regions.
Globally, Asia-Pacific is estimated to witness the fastest growth over the forecast period. The region’s robust growth is due to a surge in epilepsy cases. As per WHO, nearly 80% of people diagnosed with epilepsy reside in low and middle-income nations. Furthermore, epilepsy is the third most common neurological disorder among the older population. Thus, the rise in the geriatric population is likely to widen the scope and growth of the epilepsy devices market.

COMPETITIVE OUTLOOK

The notable companies in the epilepsy devices market include LivaNova Plc, Natus Medical Incorporated, Cadwell Industries Inc, Nihon Kohden Corporation, Compumedics Limited, Medtronic Plc, Boston Scientific Corporation, Empatica Inc, Koninklijke Philips NV, NeuroPace Inc, Drägerwerk AG & Co KGaA, Shenzhen Mindray Bio-Medical Electronics Co Ltd, and Neurosoft.
Natus Medical Incorporated is a leading provider of medical equipment, software, and services for diagnosis, monitoring, and treatments. Its products are offered across hospitals, clinics, and laboratories. The company provides products via three segments: neuro, newborn care, and hearing & balance. The neuro segments include products and services for neurodiagnostic, surgery, and care. Natus serves clients across multiple regions, including Europe, APAC, the Middle East and Africa, and North America.

TABLE OF CONTENTS

1. GLOBAL EPILEPSY DEVICES MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON THE EPILEPSY DEVICES MARKET
2.2. KEY INSIGHTS
2.2.1. GROWING USE OF TELEMEDICINE SERVICES
2.2.2. INCREASE IN DRUG AND DEVICE TRIALS FOR EPILEPSY
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTES
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. KEY BUYING IMPACT ANALYSIS
2.4.1. COMFORT & USABILITY
2.4.2. PRODUCT FEATURES
2.4.3. CONFIDENTIALITY
2.5. MARKET ATTRACTIVENESS INDEX
2.6. VENDOR SCORECARD
2.7. INDUSTRY COMPONENTS
2.8. REGULATORY FRAMEWORK
2.9. KEY MARKET STRATEGIES
2.9.1. DEVELOPMENTS & PRODUCT LAUNCHES
2.9.2. COLLABORATIONS
2.9.3. ACQUISITIONS
2.10. MARKET DRIVERS
2.10.1. COMBATING EPILEPSY THROUGH EARLY DETECTION AND DIAGNOSIS
2.10.2. RISING PREVALENCE OF EPILEPSY
2.11. MARKET CHALLENGES
2.11.1. UNAWARENESS ABOUT EPILEPSY AMONG THE GENERAL MASSES
2.11.2. LACK OF NEUROLOGY SPECIALISTS IN THE HEALTHCARE SYSTEM
2.12. MARKET OPPORTUNITIES
2.12.1. R&D ACTIVITIES DUE TO GROWING EPILEPSY CASES IN OLD PEOPLE
2.12.2. ASCENDING POST-TRAUMATIC EPILEPSY (PTE) CASES DUE TO BRAIN INJURIES
2.12.3. TECHNOLOGICAL ADVANCES IN NON-INVASIVE WEARABLE SENSORS
3. GLOBAL EPILEPSY DEVICES MARKET OUTLOOK – BY DEVICE TYPE
3.1. TRADITIONAL DEVICES
3.2. WEARABLE DEVICES
3.2.1. WATCHES
3.2.2. BRACELETS
3.2.3. CAMERA DEVICES
3.2.4. MATTRESS DEVICES
3.2.5. ANTI-SUFFOCATION PILLOWS
3.2.6. OTHER WEARABLE DEVICES
3.3. IMPLANTABLE DEVICES
4. GLOBAL EPILEPSY DEVICES MARKET OUTLOOK – BY APPLICATION
4.1. VAGUS NERVE STIMULATION
4.2. DEEP BRAIN STIMULATION
4.2.1. MOVEMENT DISORDERS
4.2.2. EPILEPSY
4.3. ACCELEROMETER
4.4. RESPONSIVE NEUROSTIMULATION
5. GLOBAL EPILEPSY DEVICES MARKET OUTLOOK – BY DETECTION AND PREDICTION DEVICE TYPE
5.1. ELECTROENCEPHALOGRAM
5.2. INTRACRANIAL EEG
5.3. SURFACE ELECTROMYOGRAPHY
5.4. ELECTROCARDIOGRAPHY
5.5. VIDEO DETECTION SYSTEMS
5.6. ELECTRODERMAL ACTIVITY
5.7. IMPLANTED ADVISORY SYSTEMS
5.8. OTHER DETECTION AND PREDICTION DEVICE TYPES
6. GLOBAL EPILEPSY DEVICES MARKET OUTLOOK – BY END-USER
6.1. HOSPITALS & CLINICS
6.2. NEUROLOGY CENTERS
6.3. HOMECARE SETTINGS
6.4. OTHER END-USERS
7. GLOBAL EPILEPSY DEVICES MARKET – REGIONAL OUTLOOK
7.1. NORTH AMERICA
7.1.1. MARKET BY DEVICE TYPE
7.1.1.1. MARKET BY WEARABLE DEVICES
7.1.2. MARKET BY APPLICATION
7.1.2.1. MARKET BY DEEP BRAIN STIMULATION
7.1.3. MARKET BY DETECTION AND PREDICTION DEVICE TYPE
7.1.4. MARKET BY END-USER
7.1.5. COUNTRY ANALYSIS
7.1.5.1. UNITED STATES
7.1.5.2. CANADA
7.2. EUROPE
7.2.1. MARKET BY DEVICE TYPE
7.2.1.1. MARKET BY WEARABLE DEVICES
7.2.2. MARKET BY APPLICATION
7.2.2.1. MARKET BY DEEP BRAIN STIMULATION
7.2.3. MARKET BY DETECTION AND PREDICTION DEVICE TYPE
7.2.4. MARKET BY END-USER
7.2.5. COUNTRY ANALYSIS
7.2.5.1. UNITED KINGDOM
7.2.5.2. GERMANY
7.2.5.3. FRANCE
7.2.5.4. ITALY
7.2.5.5. SPAIN
7.2.5.6. REST OF EUROPE
7.3. ASIA-PACIFIC
7.3.1. MARKET BY DEVICE TYPE
7.3.1.1. MARKET BY WEARABLE DEVICE
7.3.2. MARKET BY APPLICATION
7.3.2.1. MARKET BY DEEP BRAIN STIMULATION
7.3.3. MARKET BY DETECTION AND PREDICTION DEVICE TYPE
7.3.4. MARKET BY END-USER
7.3.5. COUNTRY ANALYSIS
7.3.5.1. CHINA
7.3.5.2. JAPAN
7.3.5.3. INDIA
7.3.5.4. SOUTH KOREA
7.3.5.5. ASEAN COUNTRIES
7.3.5.6. AUSTRALIA & NEW ZEALAND
7.3.5.7. REST OF ASIA-PACIFIC
7.4. LATIN AMERICA
7.4.1. MARKET BY DEVICE TYPE
7.4.1.1. MARKET BY WEARABLE DEVICE
7.4.2. MARKET BY APPLICATION
7.4.2.1. MARKET BY DEEP BRAIN STIMULATION
7.4.3. MARKET BY DETECTION AND PREDICTION DEVICE TYPE
7.4.4. MARKET BY END-USER
7.4.5. COUNTRY ANALYSIS
7.4.5.1. BRAZIL
7.4.5.2. MEXICO
7.4.5.3. REST OF LATIN AMERICA
7.5. MIDDLE EAST AND AFRICA
7.5.1. MARKET BY DEVICE TYPE
7.5.1.1. MARKET BY WEARABLE DEVICES
7.5.2. MARKET BY APPLICATION
7.5.2.1. MARKET BY DEEP BRAIN STIMULATION
7.5.3. MARKET BY DETECTION AND PREDICTION DEVICE TYPE
7.5.4. MARKET BY END-USER
7.5.5. COUNTRY ANALYSIS
7.5.5.1. UNITED ARAB EMIRATES
7.5.5.2. SAUDI ARABIA
7.5.5.3. TURKEY
7.5.5.4. SOUTH AFRICA
7.5.5.5. REST OF MIDDLE EAST & AFRICA
8. COMPETITIVE LANDSCAPE
8.1. LIVANOVA PLC
8.2. NATUS MEDICAL INCORPORATED
8.3. CADWELL INDUSTRIES INC
8.4. NIHON KOHDEN CORPORATION
8.5. COMPUMEDICS LIMITED
8.6. MEDTRONIC PLC
8.7. BOSTON SCIENTIFIC CORPORATION
8.8. EMPATICA INC
8.9. KONINKLIJKE PHILIPS NV
8.10. NEUROPACE INC
8.11. DRÄGERWERK AG & CO KGAA
8.12. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO LTD
8.13. NEUROSOFT
9. RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.2. SOURCES OF DATA
9.3. RESEARCH METHODOLOGY

LIST OF TABLES
TABLE 1: GLOBAL EPILEPSY DEVICES MARKET, BY REGIONAL OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: REGULATORY FRAMEWORK
TABLE 4: LIST OF PRODUCT LAUNCHES
TABLE 5: LIST OF COLLABORATIONS
TABLE 6: LIST OF ACQUISITIONS
TABLE 7: EXAMPLES OF ANTIEPILEPTIC DRUGS FOR THE ELDERLY AND THEIR ADVANTAGES
TABLE 8: EXAMPLE OF MOBILE EEG DEVICES
TABLE 9: GLOBAL EPILEPSY DEVICES MARKET, BY DEVICE TYPE, 2022-2028 (IN $ MILLION)
TABLE 10: GLOBAL EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2022-2028 (IN $ MILLION)
TABLE 11: GLOBAL EPILEPSY DEVICES MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 12: GLOBAL EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2022-2028 (IN $ MILLION)
TABLE 13: GLOBAL EPILEPSY DEVICES MARKET, BY DETECTION AND PREDICTION DEVICE TYPE, 2022-2028 (IN $ MILLION)
TABLE 14: GLOBAL EPILEPSY DEVICES MARKET, BY END-USER, 2022-2028 (IN $ MILLION)
TABLE 15: GLOBAL EPILEPSY DEVICES MARKET, BY REGIONAL OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 16: NORTH AMERICA EPILEPSY DEVICES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 17: NORTH AMERICA EPILEPSY DEVICES MARKET, BY DEVICE TYPE, 2022-2028 (IN $ MILLION)
TABLE 18: NORTH AMERICA EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2022-2028 (IN $ MILLION)
TABLE 19: NORTH AMERICA EPILEPSY DEVICES MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 20: NORTH AMERICA EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2022-2028 (IN $ MILLION)
TABLE 21: NORTH AMERICA EPILEPSY DEVICES MARKET, BY DETECTION AND PREDICTION DEVICE TYPE, 2022-2028 (IN $ MILLION)
TABLE 22: NORTH AMERICA EPILEPSY DEVICES MARKET, BY END-USER, 2022-2028 (IN $ MILLION)
TABLE 23: EUROPE EPILEPSY DEVICES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 24: EUROPE EPILEPSY DEVICES MARKET, BY DEVICE TYPE, 2022-2028 (IN $ MILLION)
TABLE 25: EUROPE EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2022-2028 (IN $ MILLION)
TABLE 26: EUROPE EPILEPSY DEVICES MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 27: EUROPE EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2022-2028 (IN $ MILLION)
TABLE 28: EUROPE EPILEPSY DEVICES MARKET, BY DETECTION AND PREDICTION DEVICE TYPE, 2022-2028 (IN $ MILLION)
TABLE 29: EUROPE EPILEPSY DEVICES MARKET, BY END-USER, 2022-2028 (IN $ MILLION)
TABLE 30: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 31: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY DEVICE TYPE, 2022-2028 (IN $ MILLION)
TABLE 32: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY WEARABLE DEVICE, 2022-2028 (IN $ MILLION)
TABLE 33: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 34: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2022-2028 (IN $ MILLION)
TABLE 35: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY DETECTION AND PREDICTION DEVICE TYPE, 2022-2028 (IN $ MILLION)
TABLE 36: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY END-USER, 2022-2028 (IN $ MILLION)
TABLE 37: LATIN AMERICA EPILEPSY DEVICES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 38: LATIN AMERICA EPILEPSY DEVICES MARKET, BY DEVICE TYPE, 2022-2028 (IN $ MILLION)
TABLE 39: LATIN AMERICA EPILEPSY DEVICES MARKET, BY WEARABLE DEVICE, 2022-2028 (IN $ MILLION)
TABLE 40: LATIN AMERICA EPILEPSY DEVICES MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 41: LATIN AMERICA EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2022-2028 (IN $ MILLION)
TABLE 42: LATIN AMERICA EPILEPSY DEVICES MARKET, BY DETECTION AND PREDICTION DEVICE TYPE, 2022-2028 (IN $ MILLION)
TABLE 43: LATIN AMERICA EPILEPSY DEVICES MARKET, BY END-USER, 2022-2028 (IN $ MILLION)
TABLE 44: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 45: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY DEVICE TYPE, 2022-2028 (IN $ MILLION)
TABLE 46: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2022-2028 (IN $ MILLION)
TABLE 47: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 48: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2022-2028 (IN $ MILLION)
TABLE 49: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY DETECTION AND PREDICTION DEVICE TYPE, 2022-2028 (IN $ MILLION)
TABLE 50: MIDDLE EAST AND AFRICA EPILEPSY DEVICES MARKET, BY END-USER, 2022-2028 (IN $ MILLION)

LIST OF FIGURES
FIGURE 1: KEY BUYING IMPACT ANALYSIS
FIGURE 2: MARKET ATTRACTIVENESS INDEX
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: GLOBAL EPILEPSY DEVICES MARKET, BY DEVICE TYPE, 2021 & 2028 (IN %)
FIGURE 5: GLOBAL EPILEPSY DEVICES MARKET, BY TRADITIONAL DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 6: GLOBAL EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 7: GLOBAL EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2021 & 2028 (IN %)
FIGURE 8: GLOBAL EPILEPSY DEVICES MARKET, BY WATCHES, 2022-2028 (IN $ MILLION)
FIGURE 9: GLOBAL EPILEPSY DEVICES MARKET, BY BRACELETS, 2022-2028 (IN $ MILLION)
FIGURE 10: GLOBAL EPILEPSY DEVICES MARKET, BY CAMERA DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 11: GLOBAL EPILEPSY DEVICES MARKET, BY MATTRESS DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 12: GLOBAL EPILEPSY DEVICES MARKET, BY ANTI-SUFFOCATION PILLOWS, 2022-2028 (IN $ MILLION)
FIGURE 13: GLOBAL EPILEPSY DEVICES MARKET, BY OTHER WEARABLE DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 14: GLOBAL EPILEPSY DEVICES MARKET, BY IMPLANTABLE DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 15: GLOBAL EPILEPSY DEVICES MARKET, BY APPLICATION, 2021 & 2028 (IN %)
FIGURE 16: GLOBAL EPILEPSY DEVICES MARKET, BY VAGUS NERVE STIMULATION, 2022-2028 (IN $ MILLION)
FIGURE 17: GLOBAL EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2022-2028 (IN $ MILLION)
FIGURE 18: GLOBAL EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2021 & 2028 (IN %)
FIGURE 19: GLOBAL EPILEPSY DEVICES MARKET, BY MOVEMENT DISORDERS, 2022-2028 (IN $ MILLION)
FIGURE 20: GLOBAL EPILEPSY DEVICES MARKET, BY EPILEPSY, 2022-2028 (IN $ MILLION)
FIGURE 21: GLOBAL EPILEPSY DEVICES MARKET, BY ACCELEROMETER, 2022-2028 (IN $ MILLION)
FIGURE 22: GLOBAL EPILEPSY DEVICES MARKET, BY RESPONSIVE NEUROSTIMULATION, 2022-2028 (IN $ MILLION)
FIGURE 23: GLOBAL EPILEPSY DEVICES MARKET, BY DETECTION AND PREDICTION DEVICE TYPE, 2021 & 2028 (IN %)
FIGURE 24: GLOBAL EPILEPSY DEVICES MARKET, BY ELECTROENCEPHALOGRAM, 2022-2028 (IN $ MILLION)
FIGURE 25: GLOBAL EPILEPSY DEVICES MARKET, BY INTRACRANIAL EEG, 2022-2028 (IN $ MILLION)
FIGURE 26: GLOBAL EPILEPSY DEVICES MARKET, BY SURFACE ELECTROMYOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 27: GLOBAL EPILEPSY DEVICES MARKET, BY ELECTROCARDIOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 28: GLOBAL EPILEPSY DEVICES MARKET, BY VIDEO DETECTION SYSTEMS, 2022-2028 (IN $ MILLION)
FIGURE 29: GLOBAL EPILEPSY DEVICES MARKET, BY ELECTRODERMAL ACTIVITY, 2022-2028 (IN $ MILLION)
FIGURE 30: GLOBAL EPILEPSY DEVICES MARKET, BY IMPLANTED ADVISORY SYSTEMS, 2022-2028 (IN $ MILLION)
FIGURE 31: GLOBAL EPILEPSY DEVICES MARKET, BY OTHER PREDICTION AND DETECTION DEVICE TYPES, 2022-2028 (IN $ MILLION)
FIGURE 32: GLOBAL EPILEPSY DEVICES MARKET, BY END-USER, 2021 & 2028 (IN %)
FIGURE 33: GLOBAL EPILEPSY DEVICES MARKET, BY HOSPITALS & CLINICS, 2022-2028 (IN $ MILLION)
FIGURE 34: GLOBAL EPILEPSY DEVICES MARKET, BY NEUROLOGY CENTERS, 2022-2028 (IN $ MILLION)
FIGURE 35: GLOBAL EPILEPSY DEVICES MARKET, BY HOMECARE SETTINGS, 2022-2028 (IN $ MILLION)
FIGURE 36: GLOBAL EPILEPSY DEVICES MARKET, BY OTHER END-USERS, 2022-2028 (IN $ MILLION)
FIGURE 37: GLOBAL EPILEPSY DEVICES MARKET, BY REGIONAL OUTLOOK, 2021 & 2028 (IN %)
FIGURE 38: UNITED STATES EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 39: CANADA EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 40: UNITED KINGDOM EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 41: GERMANY EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 42: FRANCE EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 43: ITALY EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 44: SPAIN EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 45: REST OF EUROPE EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 46: CHINA EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 47: JAPAN EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 48: INDIA EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 49: SOUTH KOREA EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 50: ASEAN COUNTRIES EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 51: AUSTRALIA & NEW ZEALAND EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 52: REST OF ASIA-PACIFIC EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 53: BRAZIL EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 54: MEXICO EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 55: REST OF LATIN AMERICA EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 56: UNITED ARAB EMIRATES EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 57: SAUDI ARABIA EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 58: TURKEY EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 59: SOUTH AFRICA EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 60: REST OF MIDDLE EAST & AFRICA EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)

The post GLOBAL EPILEPSY DEVICES MARKET 2022-2028 first appeared on CRI Report.

MARKET OUTLOOK

This report infers that the Asia-Pacific epilepsy devices market is expected to showcase a CAGR of 8.38% during the forecast years 2022-2028. Japan, China, India, ASEAN countries, Australia & New Zealand, South Korea, and Rest of Asia-Pacific are examined in the given region.
Japan provides a low-cost national health insurance system that is available to everyone. In this regard, several large hospitals offer a full range of medical services. Epilepsy procedures are undertaken in high volume owing to the robust local epileptic network. Considering these factors, epilepsy services are in high demand. And this trend is expected to remain over the forecast period due to a rise in patient visits to hospitals, clinics, and care facilities.
In South Korea, there is a high prevalence of epilepsy among the older population. Moreover, the rise in chronic CNS diseases is expected to surge the number of patients diagnosed with epilepsy, creating a treatment gap. In this regard, the introduction of the health insurance review and assessment (HIRA) system helps easily access information about diagnoses and medical services. Besides, the system pays for medical expenses incurred during epilepsy treatment. Therefore, such steps by the government are likely to boost the epilepsy devices market.

COMPETITIVE OUTLOOK

The key companies in the epilepsy devices market consist of Cadwell Industries Inc, Medtronic Plc, Boston Scientific Corporation, Empatica Inc, Natus Medical Incorporated, and Neurosoft.

TABLE OF CONTENTS

1. ASIA-PACIFIC EPILEPSY DEVICES MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON THE EPILEPSY DEVICES MARKET
2.2. KEY INSIGHTS
2.2.1. GROWING USE OF TELEMEDICINE SERVICES
2.2.2. INCREASE IN DRUG AND DEVICE TRIALS FOR EPILEPSY
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTES
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. KEY BUYING IMPACT ANALYSIS
2.4.1. COMFORT & USABILITY
2.4.2. PRODUCT FEATURES
2.4.3. CONFIDENTIALITY
2.5. MARKET ATTRACTIVENESS INDEX
2.6. VENDOR SCORECARD
2.7. INDUSTRY COMPONENTS
2.8. REGULATORY FRAMEWORK
2.9. KEY MARKET STRATEGIES
2.9.1. DEVELOPMENTS & PRODUCT LAUNCHES
2.9.2. COLLABORATIONS
2.9.3. ACQUISITIONS
2.10. MARKET DRIVERS
2.10.1. COMBATING EPILEPSY THROUGH EARLY DETECTION AND DIAGNOSIS
2.10.2. RISING PREVALENCE OF EPILEPSY
2.11. MARKET CHALLENGES
2.11.1. UNAWARENESS ABOUT EPILEPSY AMONG THE GENERAL MASSES
2.11.2. LACK OF NEUROLOGY SPECIALISTS IN THE HEALTHCARE SYSTEM
2.12. MARKET OPPORTUNITIES
2.12.1. R&D ACTIVITIES DUE TO GROWING EPILEPSY CASES IN OLD PEOPLE
2.12.2. ASCENDING POST-TRAUMATIC EPILEPSY (PTE) CASES DUE TO BRAIN INJURIES
2.12.3. TECHNOLOGICAL ADVANCES IN NON-INVASIVE WEARABLE SENSORS
3. ASIA-PACIFIC EPILEPSY DEVICES MARKET OUTLOOK – BY DEVICE TYPE
3.1. TRADITIONAL DEVICES
3.2. WEARABLE DEVICES
3.2.1. WATCHES
3.2.2. BRACELETS
3.2.3. CAMERA DEVICES
3.2.4. MATTRESS DEVICES
3.2.5. ANTI-SUFFOCATION PILLOWS
3.2.6. OTHER WEARABLE DEVICES
3.3. IMPLANTABLE DEVICES
4. ASIA-PACIFIC EPILEPSY DEVICES MARKET OUTLOOK – BY APPLICATION
4.1. VAGUS NERVE STIMULATION
4.2. DEEP BRAIN STIMULATION
4.2.1. MOVEMENT DISORDERS
4.2.2. EPILEPSY
4.3. ACCELEROMETER
4.4. RESPONSIVE NEUROSTIMULATION
5. ASIA-PACIFIC EPILEPSY DEVICES MARKET OUTLOOK – BY DETECTION AND PREDICTION DEVICE TYPE
5.1. ELECTROENCEPHALOGRAM
5.2. INTRACRANIAL EEG
5.3. SURFACE ELECTROMYOGRAPHY
5.4. ELECTROCARDIOGRAPHY
5.5. VIDEO DETECTION SYSTEMS
5.6. ELECTRODERMAL ACTIVITY
5.7. IMPLANTED ADVISORY SYSTEMS
5.8. OTHER DETECTION AND PREDICTION DEVICE TYPES
6. ASIA-PACIFIC EPILEPSY DEVICES MARKET OUTLOOK – BY END-USER
6.1. HOSPITALS & CLINICS
6.2. NEUROLOGY CENTERS
6.3. HOMECARE SETTINGS
6.4. OTHER END-USERS
7. ASIA-PACIFIC EPILEPSY DEVICES MARKET – COUNTRY OUTLOOK
7.1. CHINA
7.2. JAPAN
7.3. INDIA
7.4. SOUTH KOREA
7.5. ASEAN COUNTRIES
7.6. AUSTRALIA & NEW ZEALAND
7.7. REST OF ASIA-PACIFIC
8. COMPETITIVE LANDSCAPE
8.1. LIVANOVA PLC
8.2. NATUS MEDICAL INCORPORATED
8.3. CADWELL INDUSTRIES INC
8.4. NIHON KOHDEN CORPORATION
8.5. COMPUMEDICS LIMITED
8.6. MEDTRONIC PLC
8.7. BOSTON SCIENTIFIC CORPORATION
8.8. EMPATICA INC
8.9. KONINKLIJKE PHILIPS NV
8.10. NEUROPACE INC
8.11. DRÄGERWERK AG & CO KGAA
8.12. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO LTD
8.13. NEUROSOFT
9. RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.2. SOURCES OF DATA
9.3. RESEARCH METHODOLOGY

LIST OF TABLES
TABLE 1: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: REGULATORY FRAMEWORK
TABLE 4: LIST OF PRODUCT LAUNCHES
TABLE 5: LIST OF COLLABORATIONS
TABLE 6: LIST OF ACQUISITIONS
TABLE 7: EXAMPLES OF ANTIEPILEPTIC DRUGS FOR THE ELDERLY AND THEIR ADVANTAGES
TABLE 8: EXAMPLE OF MOBILE EEG DEVICES
TABLE 9: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY DEVICE TYPE, 2022-2028 (IN $ MILLION)
TABLE 10: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY WEARABLE DEVICE, 2022-2028 (IN $ MILLION)
TABLE 11: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 12: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2022-2028 (IN $ MILLION)
TABLE 13: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY DETECTION AND PREDICTION DEVICE TYPE, 2022-2028 (IN $ MILLION)
TABLE 14: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY END-USER, 2022-2028 (IN $ MILLION)
TABLE 15: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

LIST OF FIGURES
FIGURE 1: KEY BUYING IMPACT ANALYSIS
FIGURE 2: MARKET ATTRACTIVENESS INDEX
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY DEVICE TYPE, 2021 & 2028 (IN %)
FIGURE 5: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY TRADITIONAL DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 6: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 7: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2021 & 2028 (IN %)
FIGURE 8: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY WATCHES, 2022-2028 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY BRACELETS, 2022-2028 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY CAMERA DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY MATTRESS DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 12: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY ANTI-SUFFOCATION PILLOWS, 2022-2028 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY OTHER WEARABLE DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 14: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY IMPLANTABLE DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY APPLICATION, 2021 & 2028 (IN %)
FIGURE 16: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY VAGUS NERVE STIMULATION, 2022-2028 (IN $ MILLION)
FIGURE 17: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2022-2028 (IN $ MILLION)
FIGURE 18: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2021 & 2028 (IN %)
FIGURE 19: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY MOVEMENT DISORDERS, 2022-2028 (IN $ MILLION)
FIGURE 20: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY EPILEPSY, 2022-2028 (IN $ MILLION)
FIGURE 21: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY ACCELEROMETER, 2022-2028 (IN $ MILLION)
FIGURE 22: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY RESPONSIVE NEUROSTIMULATION, 2022-2028 (IN $ MILLION)
FIGURE 23: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY DETECTION AND PREDICTION DEVICE TYPE, 2021 & 2028 (IN %)
FIGURE 24: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY ELECTROENCEPHALOGRAM, 2022-2028 (IN $ MILLION)
FIGURE 25: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY INTRACRANIAL EEG, 2022-2028 (IN $ MILLION)
FIGURE 26: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY SURFACE ELECTROMYOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 27: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY ELECTROCARDIOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 28: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY VIDEO DETECTION SYSTEMS, 2022-2028 (IN $ MILLION)
FIGURE 29: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY ELECTRODERMAL ACTIVITY, 2022-2028 (IN $ MILLION)
FIGURE 30: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY IMPLANTED ADVISORY SYSTEMS, 2022-2028 (IN $ MILLION)
FIGURE 31: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY OTHER PREDICTION AND DETECTION DEVICE TYPES, 2022-2028 (IN $ MILLION)
FIGURE 32: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY END-USER, 2021 & 2028 (IN %)
FIGURE 33: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY HOSPITALS & CLINICS, 2022-2028 (IN $ MILLION)
FIGURE 34: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY NEUROLOGY CENTERS, 2022-2028 (IN $ MILLION)
FIGURE 35: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY HOMECARE SETTINGS, 2022-2028 (IN $ MILLION)
FIGURE 36: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY OTHER END-USERS, 2022-2028 (IN $ MILLION)
FIGURE 37: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 38: CHINA EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 39: JAPAN EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 40: INDIA EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 41: SOUTH KOREA EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 42: ASEAN COUNTRIES EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 43: AUSTRALIA & NEW ZEALAND EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 44: REST OF ASIA-PACIFIC EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)

The post ASIA-PACIFIC EPILEPSY DEVICES MARKET 2022-2028 first appeared on CRI Report.

MARKET OUTLOOK

This report indicates that the epilepsy devices market in Europe is anticipated to propel at a compound annual growth rate of 7.94% in revenue during the forecast years 2022-2028. Spain, France, Germany, Italy, the United Kingdom, and the Rest of Europe are evaluated in the region.
In the United Kingdom, patients diagnosed with epilepsy experienced more psychological anguish during the pandemic, leading to high-level seizures. Several young people with epilepsy experienced behavioral and mental health issues. As a result, the aggravation of pre-existing mental health and behavioral disorder is expected to increase the sales of epilepsy monitoring equipment, thereby driving the studied market.
On the other hand, the National Health Services of Italy offer free medical attention to the people. In this regard, people with chronic conditions are entitled to full exemption from paying for medical treatments, diagnostic procedures, etc. During the pandemic, chronic neurological illness lacked medical attention, resulting in high seizure frequency among patients. Therefore, such factors have increased the demand for epilepsy treatments, creating opportunities for the epilepsy devices market across Italy.

COMPETITIVE OUTLOOK

The leading companies in the epilepsy devices market include LivaNova Plc, Natus Medical Incorporated, Cadwell Industries Inc, Medtronic Plc, Koninklijke Philips NV, and Empatica Inc.

TABLE OF CONTENTS

1. EUROPE EPILEPSY DEVICES MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON THE EPILEPSY DEVICES MARKET
2.2. KEY INSIGHTS
2.2.1. GROWING USE OF TELEMEDICINE SERVICES
2.2.2. INCREASE IN DRUG AND DEVICE TRIALS FOR EPILEPSY
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTES
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. KEY BUYING IMPACT ANALYSIS
2.4.1. COMFORT & USABILITY
2.4.2. PRODUCT FEATURES
2.4.3. CONFIDENTIALITY
2.5. MARKET ATTRACTIVENESS INDEX
2.6. VENDOR SCORECARD
2.7. INDUSTRY COMPONENTS
2.8. REGULATORY FRAMEWORK
2.9. KEY MARKET STRATEGIES
2.9.1. DEVELOPMENTS & PRODUCT LAUNCHES
2.9.2. COLLABORATIONS
2.9.3. ACQUISITIONS
2.10. MARKET DRIVERS
2.10.1. COMBATING EPILEPSY THROUGH EARLY DETECTION AND DIAGNOSIS
2.10.2. RISING PREVALENCE OF EPILEPSY
2.11. MARKET CHALLENGES
2.11.1. UNAWARENESS ABOUT EPILEPSY AMONG THE GENERAL MASSES
2.11.2. LACK OF NEUROLOGY SPECIALISTS IN THE HEALTHCARE SYSTEM
2.12. MARKET OPPORTUNITIES
2.12.1. R&D ACTIVITIES DUE TO GROWING EPILEPSY CASES IN OLD PEOPLE
2.12.2. ASCENDING POST-TRAUMATIC EPILEPSY (PTE) CASES DUE TO BRAIN INJURIES
2.12.3. TECHNOLOGICAL ADVANCES IN NON-INVASIVE WEARABLE SENSORS
3. EUROPE EPILEPSY DEVICES MARKET OUTLOOK – BY DEVICE TYPE
3.1. TRADITIONAL DEVICES
3.2. WEARABLE DEVICES
3.2.1. WATCHES
3.2.2. BRACELETS
3.2.3. CAMERA DEVICES
3.2.4. MATTRESS DEVICES
3.2.5. ANTI-SUFFOCATION PILLOWS
3.2.6. OTHER WEARABLE DEVICES
3.3. IMPLANTABLE DEVICES
4. EUROPE EPILEPSY DEVICES MARKET OUTLOOK – BY APPLICATION
4.1. VAGUS NERVE STIMULATION
4.2. DEEP BRAIN STIMULATION
4.2.1. MOVEMENT DISORDERS
4.2.2. EPILEPSY
4.3. ACCELEROMETER
4.4. RESPONSIVE NEUROSTIMULATION
5. EUROPE EPILEPSY DEVICES MARKET OUTLOOK – BY DETECTION AND PREDICTION DEVICE TYPE
5.1. ELECTROENCEPHALOGRAM
5.2. INTRACRANIAL EEG
5.3. SURFACE ELECTROMYOGRAPHY
5.4. ELECTROCARDIOGRAPHY
5.5. VIDEO DETECTION SYSTEMS
5.6. ELECTRODERMAL ACTIVITY
5.7. IMPLANTED ADVISORY SYSTEMS
5.8. OTHER DETECTION AND PREDICTION DEVICE TYPES
6. EUROPE EPILEPSY DEVICES MARKET OUTLOOK – BY END-USER
6.1. HOSPITALS & CLINICS
6.2. NEUROLOGY CENTERS
6.3. HOMECARE SETTINGS
6.4. OTHER END-USERS
7. EUROPE EPILEPSY DEVICES MARKET – COUNTRY OUTLOOK
7.1. UNITED KINGDOM
7.2. GERMANY
7.3. FRANCE
7.4. ITALY
7.5. SPAIN
7.6. REST OF EUROPE
8. COMPETITIVE LANDSCAPE
8.1. LIVANOVA PLC
8.2. NATUS MEDICAL INCORPORATED
8.3. CADWELL INDUSTRIES INC
8.4. NIHON KOHDEN CORPORATION
8.5. COMPUMEDICS LIMITED
8.6. MEDTRONIC PLC
8.7. BOSTON SCIENTIFIC CORPORATION
8.8. EMPATICA INC
8.9. KONINKLIJKE PHILIPS NV
8.10. NEUROPACE INC
8.11. DRÄGERWERK AG & CO KGAA
8.12. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO LTD
8.13. NEUROSOFT
9. RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.2. SOURCES OF DATA
9.3. RESEARCH METHODOLOGY

LIST OF TABLES
TABLE 1: EUROPE EPILEPSY DEVICES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: REGULATORY FRAMEWORK
TABLE 4: LIST OF PRODUCT LAUNCHES
TABLE 5: LIST OF COLLABORATIONS
TABLE 6: LIST OF ACQUISITIONS
TABLE 7: EXAMPLES OF ANTIEPILEPTIC DRUGS FOR THE ELDERLY AND THEIR ADVANTAGES
TABLE 8: EXAMPLE OF MOBILE EEG DEVICES
TABLE 9: EUROPE EPILEPSY DEVICES MARKET, BY DEVICE TYPE, 2022-2028 (IN $ MILLION)
TABLE 10: EUROPE EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2022-2028 (IN $ MILLION)
TABLE 11: EUROPE EPILEPSY DEVICES MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 12: EUROPE EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2022-2028 (IN $ MILLION)
TABLE 13: EUROPE EPILEPSY DEVICES MARKET, BY DETECTION AND PREDICTION DEVICE TYPE, 2022-2028 (IN $ MILLION)
TABLE 14: EUROPE EPILEPSY DEVICES MARKET, BY END-USER, 2022-2028 (IN $ MILLION)
TABLE 15: EUROPE EPILEPSY DEVICES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

LIST OF FIGURES
FIGURE 1: KEY BUYING IMPACT ANALYSIS
FIGURE 2: MARKET ATTRACTIVENESS INDEX
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: EUROPE EPILEPSY DEVICES MARKET, BY DEVICE TYPE, 2021 & 2028 (IN %)
FIGURE 5: EUROPE EPILEPSY DEVICES MARKET, BY TRADITIONAL DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 6: EUROPE EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 7: EUROPE EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2021 & 2028 (IN %)
FIGURE 8: EUROPE EPILEPSY DEVICES MARKET, BY WATCHES, 2022-2028 (IN $ MILLION)
FIGURE 9: EUROPE EPILEPSY DEVICES MARKET, BY BRACELETS, 2022-2028 (IN $ MILLION)
FIGURE 10: EUROPE EPILEPSY DEVICES MARKET, BY CAMERA DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 11: EUROPE EPILEPSY DEVICES MARKET, BY MATTRESS DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 12: EUROPE EPILEPSY DEVICES MARKET, BY ANTI-SUFFOCATION PILLOWS, 2022-2028 (IN $ MILLION)
FIGURE 13: EUROPE EPILEPSY DEVICES MARKET, BY OTHER WEARABLE DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 14: EUROPE EPILEPSY DEVICES MARKET, BY IMPLANTABLE DEVICES, 2022-2028 (IN $ MILLION)
FIGURE 15: EUROPE EPILEPSY DEVICES MARKET, BY APPLICATION, 2021 & 2028 (IN %)
FIGURE 16: EUROPE EPILEPSY DEVICES MARKET, BY VAGUS NERVE STIMULATION, 2022-2028 (IN $ MILLION)
FIGURE 17: EUROPE EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2022-2028 (IN $ MILLION)
FIGURE 18: EUROPE EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2021 & 2028 (IN %)
FIGURE 19: EUROPE EPILEPSY DEVICES MARKET, BY MOVEMENT DISORDERS, 2022-2028 (IN $ MILLION)
FIGURE 20: EUROPE EPILEPSY DEVICES MARKET, BY EPILEPSY, 2022-2028 (IN $ MILLION)
FIGURE 21: EUROPE EPILEPSY DEVICES MARKET, BY ACCELEROMETER, 2022-2028 (IN $ MILLION)
FIGURE 22: EUROPE EPILEPSY DEVICES MARKET, BY RESPONSIVE NEUROSTIMULATION, 2022-2028 (IN $ MILLION)
FIGURE 23: EUROPE EPILEPSY DEVICES MARKET, BY DETECTION AND PREDICTION DEVICE TYPE, 2021 & 2028 (IN %)
FIGURE 24: EUROPE EPILEPSY DEVICES MARKET, BY ELECTROENCEPHALOGRAM, 2022-2028 (IN $ MILLION)
FIGURE 25: EUROPE EPILEPSY DEVICES MARKET, BY INTRACRANIAL EEG, 2022-2028 (IN $ MILLION)
FIGURE 26: EUROPE EPILEPSY DEVICES MARKET, BY SURFACE ELECTROMYOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 27: EUROPE EPILEPSY DEVICES MARKET, BY ELECTROCARDIOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 28: EUROPE EPILEPSY DEVICES MARKET, BY VIDEO DETECTION SYSTEMS, 2022-2028 (IN $ MILLION)
FIGURE 29: EUROPE EPILEPSY DEVICES MARKET, BY ELECTRODERMAL ACTIVITY, 2022-2028 (IN $ MILLION)
FIGURE 30: EUROPE EPILEPSY DEVICES MARKET, BY IMPLANTED ADVISORY SYSTEMS, 2022-2028 (IN $ MILLION)
FIGURE 31: EUROPE EPILEPSY DEVICES MARKET, BY OTHER PREDICTION AND DETECTION DEVICE TYPES, 2022-2028 (IN $ MILLION)
FIGURE 32: EUROPE EPILEPSY DEVICES MARKET, BY END-USER, 2021 & 2028 (IN %)
FIGURE 33: EUROPE EPILEPSY DEVICES MARKET, BY HOSPITALS & CLINICS, 2022-2028 (IN $ MILLION)
FIGURE 34: EUROPE EPILEPSY DEVICES MARKET, BY NEUROLOGY CENTERS, 2022-2028 (IN $ MILLION)
FIGURE 35: EUROPE EPILEPSY DEVICES MARKET, BY HOMECARE SETTINGS, 2022-2028 (IN $ MILLION)
FIGURE 36: EUROPE EPILEPSY DEVICES MARKET, BY OTHER END-USERS, 2022-2028 (IN $ MILLION)
FIGURE 37: EUROPE EPILEPSY DEVICES MARKET, BY COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 38: UNITED KINGDOM EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 39: GERMANY EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 40: FRANCE EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 41: ITALY EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 42: SPAIN EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 43: REST OF EUROPE EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)

The post EUROPE EPILEPSY DEVICES MARKET 2022-2028 first appeared on CRI Report.

Epilepsy Devices market to surpass USD 1115.3 million by 2030 from USD 587.4 million in 2020 at a CAGR of 6.62% in the coming years, i.e., 2021-30.

Product Overview
Epilepsy is a chronic neurological condition that produces repeated unprovoked seizures, which are characterized by undetected episodes of uncontrollable movement involving either a portion or full body. The underlying cause of epilepsy, however, remains unclear. Epilepsy can be caused by strokes, trauma, brain tumors, infections, or birth defects in certain people. Because the condition is more common in children than in adults, general practitioners are more likely to see patients with epilepsy in their everyday practice. Depending on the symptoms of epilepsy, blood tests such as complete blood count, magnetic resonance imaging (MRI), computed tomography scanning (CT), and electroencephalograms (EEG) are used to diagnose the condition. The therapeutic gadgets provide novel treatment alternatives for epilepsy.

Market Highlights
Epilepsy Devices market is expected to project a notable CAGR of 6.62% in 2030
The increasing incidence of epilepsy among the geriatric population, rising occurrences of brain injuries due to road accidents, a huge patient pool suffering from neurological diseases, and expanding research funding in epilepsy are all contributing to the global market’s growth.

Epilepsy Devices Market: Segments
Conventional devices segment to grow with the highest CAGR during 2020-30
Epilepsy Devices market is segmented by Product into Conventional devices and Wearable devices. Among these Conventional devices is expected to dominate the market during the forecast period. The extensive use of traditional EEG equipment in hospitals and clinics, the rising need for epilepsy monitoring in clinical trials, and the availability of payment for EEG treatments in developed nations all contribute to the segment’s rise.

Hospitals & Clinics segment to grow with the highest CAGR during 2020-30
Epilepsy Devices market is segmented by End-User into Hospitals & Clinics, Forensic and Pharmaceutical manufacturing. Among these, the Hospitals & Clinics category had the highest revenue share in 2020. EEG monitoring and emergency medical services are most commonly used in hospitals and clinics. The market is expected to provide profitable opportunities, particularly in developing nations.

Market Dynamics
Drivers
Need for continuous monitoring to rise market growth
Continuous monitoring is required in severely ill epileptic patients to detect non-convulsive episodes (NCS). The cerebral cortical function is assessed by continuous monitoring. NCS is a condition that can affect children with encephalopathy. Adults’ NCS outcomes change with time, possibly worsening their health. As a result, the demand for EEG systems rises as the requirement for continuous monitoring grows.

Increasing awareness
The global epilepsy treatment devices market is anticipated to develop due to increased awareness and technical improvements in epilepsy treatment options.

Restraint
Lack of healthcare facilities
The global epilepsy treatment devices market is projected to be hampered by a lack of healthcare facilities in low and middle-income countries, as well as a reluctance to accept epilepsy therapy.

Epilepsy Devices Market: Key Players
Boston Scientific Corporation

Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis

Medpage Ltd. (Easylink UK)
Cerbomed GmbH (TVNS Technologies GmbH)
Liva Nova (Cyberonics)
Compumedics
Nihon Kohden
MC10
Empatica Inc
Medtronic Plc
Neuropace Inc

Epilepsy Devices Market: Regions
Epilepsy Devices market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, Asia Pacific, and the Middle East, and Africa. Epilepsy Devices market in North America held the largest market share in the year 2019. In the forecast period, the Epilepsy Devices market is expected to be dominated by North America. This is primarily due to the large number of businesses operating in the region, government regulations, and rising healthcare expenditure.

Epilepsy Devices Market is further segmented by region into:
North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil, and Rest of Latin America
Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, and Rest of Europe
Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – China, Japan, Australia, and Rest of APAC
Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa, and Rest of MENA

Epilepsy Devices report also contains analysis on:
Epilepsy Devices Segments:
By Product:
Conventional devices
Wearable devices
By End-User:
Home care settings
Clinics
Hospitals
Epilepsy Devices Market Dynamics
Epilepsy Devices Market Size
Supply & Demand
Current Market Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints

Epilepsy Devices Market Report Scope and Segmentation
Report Attribute Details
Market size value in 2021 USD 626.1 million
Revenue forecast in 2030 USD 1115.3 million
Growth Rate CAGR of 6.62% from 2021 to 2030
Base year for estimation 2020
Quantitative units Revenue in USD million and CAGR from 2021 to 2030
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered Product, End-user, and Region
Regional scope North America; Europe; Asia Pacific; Latin America; Middle East & Africa (MEA)
Key companies profiled Boston Scientific Corporation, Medpage Ltd. (Easylink UK), Cerbomed GmbH (TVNS Technologies GmbH), Liva Nova (Cyberonics), Compumedics, Nihon Kohden, MC10, Empatica Inc, Medtronic Plc, Neuropace Inc and Other Prominent Players.

Frequently Asked Questions
How big is the Epilepsy Devices market?
What is the Epilepsy Devices market growth?
Which segment accounted for the largest Epilepsy Devices market share?
Who are the key players in the Epilepsy Devices market?
What are the factors driving the Epilepsy Devices market?

The post Global Epilepsy Devices Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030 first appeared on CRI Report.